Bicara Therapeutics Inc
BCAX
NASDAQ
Biotechnology
$24.28
USD
+0.65 (+2.75%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.82B
Volume 479.9K
Price Target
$23.00 – $39.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $39.00 and a min estimate of $23.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$31.00
-$0.4 vs prior
Implied Upside
+27.7%
-1.6% vs prior
Analyst Covering
2
-6 vs prior period
Consensus
Hold
Declined vs prior
Signal Quality
Consensus Freshness
20%
Many ratings are older - consensus may be less current
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Hold
1 Buy
1 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Jeet Mukherjee | BTIG | Buy | Maintained | 3 days ago | Plus | Plus | Plus |
Eva Fortea Verdejo | Wells Fargo | Hold | Maintained | 3 days ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
AVBP
ArriVent BioPharma Inc
$29.51
▼ -1.6%
TYRA
Tyra Biosciences Inc
$25.29
▲ +1.1%
FBRX
Forte Biosciences Inc
$76.83
▼ -0.0%
ABSI
Absci Corp
$9.18
▼ -3.0%
XNCR
Xencor Inc
$23.34
▲ +1.5%
NTLA
Intellia Therapeutics Inc
$11.91
▲ +0.7%
JBIO
Jade Biosciences Inc
$24.71
▲ +3.8%
ZYME
Zymeworks Inc
$25.12
▼ -2.5%
VIR
Vir Biotechnology Inc
$9.24
▲ +2.7%
TRAX
First Tracks Biotherapeutics Inc
$44.04
▲ +0.0%